Advances and Controversies in HIV Prevention and Treatment: Updates from ID Week 2019
Michelle S. Cespedes, MD, MS
Associate Professor of Medicine, Infectious Diseases
Icahn School of Medicine at Mount Sinai, New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2019. All rights reserved.
Michelle S. Cespedes is an Associate Professor of Medicine in the Division of Infectious Disease at the Icahn School of Medicine at Mount Sinai. Her research areas of interest are HIV prevention in high risk populations, complications and comorbidities of HIV, with an emphasis on HPV, and HIV related women's health issues. In 2014, she was named the co-Director of ID Division’s Clinical and Translational Research Center at Mount Sinai and is the clinical research site leader of Mount Sinai’s Comprehensive Health Program Downtown.
At the completion of this educational session, learners will:
- Understand new data on the optimal management of HIV antiretroviral therapy.
- Know about investigational drugs being developed for the treatment of HIV.
- Be aware of advances in the treatment of comorbidities of HIV infection, including HCV.
This CME activity has approved for
AMA PRA Category 1 Credit™ on November 12, 2019 and will terminate November 11, 2022.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Michelle S. Cespedes (Presenter) had the following personal financial relationships in the prior 12 months with manufacturers of the products or services that may be presented in this CME activity: Advisory Board Member to Gilead, and ViiV. Dr. Cespedes submitted her slides in advance for adequate peer review and will support her presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; and Merck & Co.
To obtain CME credit for this PRN program, please visit the
PRN Courses Page at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
